Oncolytics Biotech Inc. (ONCY) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 16K | 0 | 0 | 0 | 0 | 0 | 0 | 71.62K | 123K | 107K | 76.79K | 71.48K | 71.72K | 72.93K | 74.89K | 76.44K | 77.03K | 76.93K | 67.08K | 133.44K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -16K | 0 | 0 | 0 | 0 | 0 | 0 | -71.62K | -123K | -107K | -76.79K | -71.48K | -71.72K | -72.93K | -74.89K | -76.44K | -77.03K | -76.93K | -67.08K | -133.44K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | 100% | 100% | 100% | 100% | -0.2% | -71.51% | -46.72% | -2.54% | 6.49% | 6.89% | 5.2% | -11.65% | 42.71% | 8.62% | - | - | - |
| Operating Expenses | 9.27M | 2.18M | 13.84M | 5.71M | 7M | 8.44M | 9.9M | 5.72M | 8.6M | 8.74M | 8.16M | 5.26M | 4.91M | 6.19M | 4.56M | 4.66M | 4.9M | 5.84M | 4.82M | 5.34M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 4.71M | 2.18M | 6.23M | 2.8M | 2.82M | 3.46M | 3.1M | 2.39M | 2.86M | 4.08M | 3.83M | 2.5M | 2.29M | 2.63M | 1.75M | 2.15M | 1.98M | 2.92M | 2.22M | 2.73M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 4.55M | 0 | 7.51M | 2.81M | 4.08M | 4.55M | 6.79M | 3.33M | 5.74M | 4.66M | 4.33M | 2.76M | 2.62M | 3.57M | 2.82M | 2.51M | 2.93M | 2.92M | 2.6M | 2.61M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 93K | 94K | 97K | 424K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.28M | -2.18M | -13.84M | -5.71M | -7M | -8.44M | -9.9M | -5.79M | -8.73M | -8.85M | -8.24M | -5.33M | -4.98M | -6.27M | -4.64M | -4.73M | -4.98M | -5.91M | -4.88M | -5.48M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -32.6% | 74.16% | -39.81% | 1.42% | 19.79% | 4.66% | -20.18% | -8.58% | -75.27% | -41.2% | -77.54% | -12.59% | 0.06% | -5.97% | 5.02% | 13.54% | -6.9% | 26.74% | 22.66% | 1.28% |
| EBITDA | -9.27M | -2.18M | -13.75M | -5.61M | -6.9M | -8.34M | -9.79M | -5.72M | -8.6M | -8.74M | -8.16M | -5.26M | -4.91M | -6.19M | -4.56M | -4.66M | -4.9M | -5.84M | -4.82M | -5.34M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -34.24% | 73.86% | -40.36% | 1.83% | 19.77% | 4.61% | -20.02% | -8.69% | -75.32% | -41.14% | -78.77% | -12.9% | -0.05% | -6.12% | 5.25% | 12.81% | -7.19% | 26.72% | 22.37% | 1.65% |
| D&A (Non-Cash Add-back) | 16K | 0 | 93K | 94K | 97K | 98K | 105K | 71.62K | 123K | 107K | 76.79K | 71.48K | 71.72K | 72.93K | 74.89K | 76.44K | 77.03K | 76.93K | 67.08K | 133.44K |
| EBIT | -9.28M | -2.18M | -14.65M | -5.71M | -7M | -8.44M | -9.9M | -5.23M | -8.73M | -8.85M | -7.39M | -5.51M | -4.76M | -6.26M | -3.37M | -3.97M | -5.35M | -6.12M | -3.86M | -5.9M |
| Net Interest Income | 44K | 59K | 100K | 104K | 123K | 152K | 261K | 340K | 446K | 489K | 305K | 267K | 265K | 313.75K | 146K | 49K | 18K | 22.16K | 25.74K | 29.22K |
| Interest Income | 44K | 59K | 100K | 104K | 123K | 152K | 261K | 340K | 446K | 489K | 305K | 267K | 265K | 313.75K | 146K | 49K | 18K | 22.16K | 25.74K | 29.22K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 38K | 919K | -812K | -374K | 312K | 443K | 368K | 554.72K | 1.83M | 4.94M | 842.49K | -174.23K | 219.59K | 8.1K | 1.27M | 764.46K | -369.83K | -201.59K | 1.02M | -425.13K |
| Pretax Income | -9.24M | -1.26M | -14.65M | -6.08M | -6.69M | -7.99M | -9.53M | -5.23M | -6.89M | -3.91M | -7.39M | -5.51M | -4.76M | -6.26M | -3.37M | -3.97M | -5.35M | -6.12M | -3.86M | -5.9M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 246K | -252K | 85K | 0 | 23K | 12K | 69.43K | 0 | 43K | 5.22K | 34.99K | 0 | 41.98K | 1.99K | 19.44K | 0 | 33.54K | 5.67K | 0 |
| Effective Tax Rate % | 0% | -19.51% | 1.72% | -1.4% | 0% | -0.29% | -0.13% | -1.33% | 0% | -1.1% | -0.07% | -0.64% | 0% | -0.67% | -0.06% | -0.49% | 0% | -0.55% | -0.15% | 0% |
| Net Income | -12.89M | -1.51M | -14.4M | -6.17M | -6.69M | -8.02M | -9.54M | -5.3M | -6.89M | -3.95M | -7.4M | -5.54M | -4.76M | -6.3M | -3.37M | -3.99M | -5.35M | -6.15M | -3.87M | -5.9M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -92.76% | 81.2% | -50.9% | -16.25% | 3% | -103.01% | -28.96% | 4.28% | -44.86% | 37.33% | -119.3% | -38.86% | 11.07% | -2.47% | 12.73% | 32.39% | -5.31% | 34.09% | 42.71% | 13.56% |
| Net Income (Continuing) | -9.24M | -1.51M | -14.4M | -6.17M | -6.69M | -8.02M | -9.54M | -5.3M | -6.89M | -3.95M | -7.4M | -5.54M | -4.76M | -6.3M | -3.37M | -3.99M | -5.35M | -6.15M | -3.87M | -5.9M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.11 | -0.01 | -0.14 | -0.07 | -0.08 | -0.10 | -0.12 | -0.10 | -0.09 | -0.05 | -0.14 | -0.12 | -0.10 | -0.14 | -0.08 | -0.09 | -0.14 | -0.14 | -0.09 | -0.13 |
| EPS Growth % | -39.24% | 86.1% | -16.67% | 29.04% | 13.76% | -86.57% | 14.29% | 20.5% | 6.53% | 61.71% | -85.19% | -35.9% | 30% | 0% | 14.67% | 32.08% | -7.69% | 36.36% | 44.63% | 23.53% |
| EPS (Basic) | -0.11 | -0.01 | -0.14 | -0.07 | -0.08 | -0.10 | -0.12 | -0.10 | -0.09 | -0.05 | -0.14 | -0.12 | -0.10 | -0.14 | -0.08 | -0.09 | -0.14 | -0.14 | -0.09 | -0.13 |
| Diluted Shares Outstanding | 112.29M | 95.86M | 101.32M | 91M | 84.63M | 76.09M | 77.02M | 76.09M | 75.24M | 73.73M | 69.8M | 64.47M | 62.34M | 59.51M | 58.33M | 57.67M | 56.58M | 54.96M | 54.96M | 54.33M |
| Basic Shares Outstanding | 112.29M | 95.86M | 101.32M | 91M | 84.63M | 76.09M | 77.02M | 76.09M | 75.24M | 73.73M | 69.8M | 64.47M | 62.34M | 59.51M | 58.33M | 57.67M | 56.58M | 54.96M | 54.96M | 54.33M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |